Defective protein trafficking of HERG K+ channels in human congenital long QT syndrome

Craig T. January, Qiuming Gong, Zhengfeng Zhou

    Research output: Contribution to journalReview articlepeer-review

    3 Scopus citations


    It is now clear that LQT2 represents a large number of mutations throughout the HERG channel protein that cause a decrease in IKr amplitude to increase in the QT interval. At least for LQT2, this is a disease of increasing complexity that depends on many mechanisms involving abnormalities in HERG protein processing and trafficking, HERG channel function and subunit co-assembly that vary from one mutation to the next. In a simplified form this is shown in Figure 5. For many LQT2 mutations, the dominant mechanism appears to be retention and degradation of abnormal protein in the endoplasmic reticulum and its failure to traffic to the plasma, even if the channel is capable of functioning biophysically. Thus, in patients the emerging data support the concept that it is the interaction of several mechanisms that determines IKr properties, and contributes to the variable expression and severity of the LQT2 phenotype. As our understanding of these mechanisms and their interactions increases, this offers the potential for new therapeutic approaches.

    Original languageEnglish (US)
    Pages (from-to)27-34
    Number of pages8
    JournalPharmaceutical News
    Issue number4
    StatePublished - Dec 1 2000

    ASJC Scopus subject areas

    • Pharmaceutical Science


    Dive into the research topics of 'Defective protein trafficking of HERG K+ channels in human congenital long QT syndrome'. Together they form a unique fingerprint.

    Cite this